JDRF T1D FUND
The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Through partnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially m... ore private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.
JDRF T1D FUND
Founded:
2016-12-01
Status:
Active
Contact:
212-689-2860
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Intrinsic Capital Partners
A private equity fund dedicated to investing in promising growth businesses in the emerging legal cannabis industry.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-07 | Code Biotherapeutics | JDRF T1D Fund investment in Series A - Code Biotherapeutics | 75 M USD |
| 2022-05-16 | Kriya Therapeutics | JDRF T1D Fund investment in Series C - Kriya Therapeutics | 270 M USD |
| 2022-03-29 | Jaguar Gene Therapy | JDRF T1D Fund investment in Venture Round - Jaguar Gene Therapy | N/A |
| 2021-11-02 | Biolinq | JDRF T1D Fund investment in Series B - Biolinq | 100 M USD |
| 2021-08-11 | GentiBio | JDRF T1D Fund investment in Series A - GentiBio | 157 M USD |
| 2021-08-04 | Sonoma BioTherapeutics | JDRF T1D Fund investment in Series B - Sonoma BioTherapeutics | 265 M USD |
| 2021-07-14 | Kriya Therapeutics | JDRF T1D Fund investment in Series B - Kriya Therapeutics | 100 M USD |
| 2021-06-23 | Abata Therapeutics | JDRF T1D Fund investment in Series A - Abata Therapeutics | 95 M USD |
| 2021-06-16 | Veralox Therapeutics | JDRF T1D Fund investment in Series A - Veralox Therapeutics | 16.6 M USD |
| 2021-04-20 | Code Biotherapeutics | JDRF T1D Fund investment in Seed Round - Code Biotherapeutics | 10 M USD |